NCT04744610

Brief Summary

Background of the study: Hysterosalpingography (HSG) is widely used for the female infertility workup. Many studies have demonstrated that the use of oil-soluble contrast medium (OSCM) ethiodized oil for HSG surgery can improve pregnancy rates. However,The 24-hour delayed radiographs of OSCM HSG also brought some inconvenience to the patients , for example, patients need to make two trips to the hospital. Objective of the study: The purpose of this study was to compare OSCM HSGs using 4-hour and 24-hour delayed radiographs in terms of diagnosing tubal patency and identifying the presence of pelvic adhesions. Study design: Prospective, open label, self - controlled study Study population: Infertile patients scheduled for an OSCM HSG

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 22, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 6, 2021

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 9, 2021

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

February 9, 2021

Status Verified

January 1, 2021

Enrollment Period

3 months

First QC Date

January 6, 2021

Last Update Submit

February 6, 2021

Conditions

Keywords

InfertilityHysterosalpingographyOil-soluble contrast medium

Outcome Measures

Primary Outcomes (1)

  • Difference in diagnosis of fallopian tube patency between 4 hours delayed radiographs and 24 hours delayed radiographs.

    The diagnostic results of 4 hours delayed radiographs and 24 hours delayed radiographs were evaluated by two radiologists with more than 5 years' working experience. In case of any dispute, the two doctors reached an agreement after discussion. The results were defined as : completely consistent; mostly consistent;partly consistent;completely different.

    The evaluation was performed within 1 day after completion of the 24 hours delayed radiographs.

Secondary Outcomes (3)

  • Difference in the diagnosis of patency of proximal fallopian tube between 4 hours delayed radiographs and 24 hours delayed radiographs

    The evaluation was performed within 1 day after completion of the 24 hours delayed radiographs.

  • Difference in the diagnosis of patency of distal fallopian tube between 4 hours delayed radiographs and 24 hours delayed radiographs

    The evaluation was performed within 1 day after completion of the 24 hours delayed radiographs.

  • Difference in the diagnosis of pelvic lesions between 4 hours delayed radiographs and 24 hours delayed radiographs.

    The evaluation was performed within 1 day after completion of the 24 hours delayed radiographs.

Other Outcomes (1)

  • The incidence of adverse events and serious adverse events.

    Within one month after hysterosalpingography procedure.

Study Arms (1)

4-hour delayed radiographs

OTHER

The follow-up radiographs was taken 4 h after the HSG operation.

Diagnostic Test: Add 4-hour delayed radiographs

Interventions

Normal patients only need to take delayed radiographs 24h after HSG operation. In this study, 4-hour delayed radiographs were added to the 24-hour delayed radiographs, so that the patients had to take one more delayed radiographs .

4-hour delayed radiographs

Eligibility Criteria

Age21 Years - 38 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Having spontaneous ovulation or inducing ovulation;
  • Infertility lasting for 12 months;
  • Conforms to the indications of hysterosalpingography;
  • Understand and sign the informed consent;

You may not qualify if:

  • Iodine allergy or hyperthyroidism
  • Acute genital tract inflammation or abnormal leucorrhea examination;
  • Abnormal vaginal bleeding;
  • Fever or preoperative temperature higher than 37.5℃ within 3 days before angiography;
  • Severe insufficiency of cardiopulmonary or liver function;
  • During pregnancy and menstruation;
  • With complications that may cause subjects to be unable to follow the study plan or even endanger the patient's safety or social environment;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Women's Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, China

RECRUITING

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Yimin Zhu

    Women's Hospital School Of Medicine Zhejiang University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 6, 2021

First Posted

February 9, 2021

Study Start

October 22, 2020

Primary Completion

February 1, 2021

Study Completion

March 1, 2021

Last Updated

February 9, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations